Alpha-1 Research Registry
Alpha-1 Research Registry Protocol
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- No age limits stated
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
The Alpha-1 Research Registry is a private database for people with Alpha-1 Antitrypsin Deficiency and people who carry a gene for it. It supports research to help develop better treatments and a cure for Alpha-1.
The Alpha-1 Research Registry is a confidential database made up of individuals diagnosed with Alpha-1 Antitrypsin Deficiency (Alpha-1) and individuals identified as Alpha-1 carriers. The Registry was established to facilitate research initiatives and promote the development of improved treatments and a cure for Alpha-1.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- You have been diagnosed with Alpha-1 Antitrypsin Deficiency, such as the PiZZ, PiZNull, or PiSZ types.
- You are an Alpha-1 carrier, meaning you carry a gene for it, such as the PiMZ or PiMS types.
Who can't join
- You do not give informed consent, which means agreeing to join after learning what is involved.
- You are healthy and have the normal MM gene type.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Patients diagnosed with Alpha-1 Antitrypsin Deficiency (PiZZ, PiZNull, PiSZ etc.) * Alpha-1 carriers (PiMZ, PiMS etc.) Exclusion Criteria: * Failure to provide informed consent * Normal healthy individuals (MM)
Study sites (1)
FL
- Alpha-1 Foundation · Coral Gables, FL 33134Alison Keaveny, MBBS · Study contact · 1-877-228-7321 ext. 252 · akeaveny@alpha1.orgNadine Nuchovich, MPH · Study contact · 1-877-228-7321 ext. 245 · nnuchovich@alpha1.orgJeanine D'Armiento, MD, PhD · Principal investigatorMore trials in Coral Gables